Immunic hosts progressive multiple sclerosis R&D day
IMUX•Immunic will host a virtual progressive multiple sclerosis R&D Day on November 5, 2026, at 12:30 p.m. ET, with discussions on vidofludimus calcium and plans to initiate a Phase 3 trial later in 2026.
1. R&D day plans
Immunic will host a virtual progressive multiple sclerosis R&D Day on November 5, 2026, at 12:30 p.m. ET. Discussions will focus on vidofludimus calcium’s potential in progressive MS, including plans to initiate a Phase 3 trial later in 2026.
